A European prospective observational study of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC): PREMISEHeather Payne, Marco De Santis, Ugo De Giorgi et al.|European Urology Open Science|2020Cited by 1
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive OncologyE. Martin, Valérie Seegers, Karine Le Malicot et al.|Current Oncology|2024Cited by 1